 |
|
|
|
 |
Guido Dalbagni, MD, FACS
I am a urologic surgeon with expertise in the treatment of urologic tumors. My primary area of interest is bladder cancer. I am currently heading clinical trials at Memorial Sloan-Kettering to evaluate new therapies for the treatment of high-risk superficial bladder cancer in patients who are resistant to bacillus Calmette-Guérin (BCG) therapy, the standard treatment. Another area of expertise is nerve-sparing radical cystectomy followed by bladder reconstruction. I have written a number of articles, and I am on the editorial board and a reviewer for several peer-reviewed journals.
Appointments for New Patients
646-497-9068
Phone
646-422-4394
Education
MD, Cairo University Faculty of Medicine (Egypt); MD, University of Parma (Italy)
Residencies
Cabrini Medical Center (New York); New York University Medical Center
Fellowships
Memorial Sloan-Kettering Cancer Center
Board Certifications
Urology
Clinical Expertise
Bladder Cancer; Upper Tract; Urologic Oncology; Kidney Cancer
Department & Service
|
|
|
|
|
|
